Cargando…
MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection
Approximately 370 million people worldwide are chronically infected with hepatitis B virus (HBV). Despite the success of the prophylactic HBV vaccine, no therapeutic vaccine or other immunotherapy modality is available for treatment of chronically infected individuals. Clearance of HBV depends on ro...
Autores principales: | Comber, Joseph D., Karabudak, Aykan, Shetty, Vivekananda, Testa, James S., Huang, Xiaofang, Philip, Ramila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058288/ https://www.ncbi.nlm.nih.gov/pubmed/24971174 http://dx.doi.org/10.1155/2014/860562 |
Ejemplares similares
-
MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response
por: Testa, James S., et al.
Publicado: (2012) -
Targeted multi-epitope therapeutic vaccine for the treatment of invasive glioblastoma multiforme
por: Huang, Xiaofang, et al.
Publicado: (2015) -
HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013) -
Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019) -
Involvement of autophagy in MHC class I antigen presentation
por: Øynebråten, Inger
Publicado: (2020)